FDA Inspection 1020864 — Fareva Pau
The FDA completed an inspection of Fareva Pau on Apr 13, 2017 in Idron. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Idron (France)